Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
877.79
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
12,349
Open
877.79
Bid (Size)
867.15 (1)
Ask (Size)
869.50 (1)
Prev. Close
877.79
Today's Range
877.79 - 877.79
52wk Range
516.57 - 972.53
Shares Outstanding
N/A
Dividend Yield
0.51%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
This Is the Best Pharma Stock to Invest $1,000 in Right Now
September 29, 2024
Eli Lilly could keep growing for years without changing its strategy.
Via
The Motley Fool
Eli Lilly And Co DCF Valuation: Is The Stock Undervalued?
September 29, 2024
Based on the DCF valuation, the stock is overvalued. The DCF value of $632.57 share is lower than the current market price of $921.49. The Margin of Safety is -45.67%.
Via
Talk Markets
Performance
YTD
+48.23%
+48.23%
1 Month
-8.57%
-8.57%
3 Month
-4.00%
-4.00%
6 Month
+15.42%
+15.42%
1 Year
+63.07%
+63.07%
More News
Read More
Success in This New Battleground Could Make Eli Lilly and Novo Nordisk Stock Absolutely Fly for Years
September 28, 2024
Via
The Motley Fool
1 Unstoppable Growth Stock Heading to $2 Trillion by 2030
September 28, 2024
Via
The Motley Fool
Got $1,000? 2 Superior Growth Stocks to Buy and Hold Forever
September 28, 2024
Via
The Motley Fool
Stocks To Buy And Hold For 5 Years
September 27, 2024
Via
Talk Markets
Is NYSE:LLY a Fit for high Growth Investing Strategies?
September 26, 2024
Via
Chartmill
Eli Lilly Unusual Options Activity
September 25, 2024
Via
Benzinga
$1000 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today
September 24, 2024
Via
Benzinga
Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason
September 27, 2024
Via
The Motley Fool
BioAge Labs, An Obesity Newcomer And Eli Lilly Partner, Rallies 28% On Upsized IPO
September 26, 2024
Via
Investor's Business Daily
Novo Nordisk's $600 Million Gambit Could Be a Game Changer for the Stock. Here's Why.
September 26, 2024
Via
The Motley Fool
Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments
September 25, 2024
Via
Benzinga
Popular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid Users
September 25, 2024
Via
Benzinga
Spotlight on Eli Lilly: Analyzing the Surge in Options Activity
September 23, 2024
Via
Benzinga
Can Novo Nordisk's Weight Loss Drug Ozempic Help Stem The Devastating Addiction Crisis? New Research Says Yes
September 25, 2024
Via
Benzinga
Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs
September 25, 2024
Via
Benzinga
Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years
September 25, 2024
Via
Benzinga
Exposures
Product Safety
Why This Stock Could Be the Nvidia of Healthcare
September 25, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
September 24, 2024
Via
MarketBeat
Eli Lilly's Early Alzheimer's Treatment Donanemab Scores Japanese Approval, Its Second Largest Market
September 24, 2024
Via
Benzinga
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
September 24, 2024
Via
FinancialNewsMedia
Exposures
Product Safety
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse
September 24, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Investing in This Healthcare Stock Could Be Like Catching Nvidia at the Dawn of the AI Boom
September 22, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)
September 21, 2024
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.